Iprabut 2,5 ml Solution for nebulisation
PDF Leaflet Revision Date: 28 September 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Management of reversible bronchospasm associated with obstructive pulmonary disease.
Dosage (summary)
Adults: 1 unit dose vial for acute attacks; 1 vial 3-4 times daily for maintenance.
Onset of Action / Duration
Onset: 30 mins, Duration: 4-6 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; potential fetal harm at high doses.
Key Drug Interactions
- Xanthine derivatives
- Beta-blockers
- Monoamine oxidase inhibitors
- Tricyclic antidepressants
Contraindications
- Hypersensitivity to components
- Hypertrophic obstructive cardiomyopathy
- Children under 12
Common side effects
- Headache
- Throat irritation
- Cough
- Dry mouth
- Dizziness
Counselling Points
- Use as directed
- Avoid eye exposure
- Monitor for worsening symptoms
Serious warnings
- Paradoxical bronchospasm
- Ocular complications
- Cardiovascular effects
Important Disclaimer
The Iprabut 2,5 ml Solution for nebulisation professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
